S&P Equity Research downgrades Hologic (Nasdaq: HOLX) from Strong Buy to Buy.

S&P analyst, R. Gold, says, "Mar-Q ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE